Patents by Inventor Timothy Michael Skerry

Timothy Michael Skerry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent
    Patent number: 9556268
    Abstract: The present invention relates to agents which modulate the effect of a RAMP (Receptor Activity Modifying Protein) protein on a Calcitonin Receptor Like Receptor (CRLR). Also included in the present invention are methods and uses of such agents and assays for identifying such agents. The agents of the present disclosure may be used in the treatment of, for example, cancer, obesity and other disorders.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: January 31, 2017
    Assignee: Medella Therapeutics Ltd.
    Inventors: Timothy Michael Skerry, Gareth Owain Richards
  • THERAPEUTIC AGENT
    Publication number: 20150037344
    Abstract: The present invention relates to agents which modulate the effect of a RAMP (Receptor Activity Modifying Protein) protein on a Calcitonin Receptor Like Receptor (CRLR). Also included in the present invention are methods and uses of such agents and assays for identifying such agents. The agents of the present disclosure may be used in the treatment of, for example, cancer, obesity and other disorders.
    Type: Application
    Filed: October 9, 2014
    Publication date: February 5, 2015
    Inventors: Timothy Michael SKERRY, Gareth Owain RICHARDS
  • Therapeutic agent
    Patent number: 8895005
    Abstract: The present invention relates to agents which modulate the effect of a RAMP (Receptor Activity Modifying Protein) protein on a Calcitonin Receptor Like Receptor (CRLR). Also included in the present invention are methods and uses of such agents and assays for identifying such agents. The agents of the present disclosure may be used in the treatment of, for example, cancer, obesity and other disorders.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: November 25, 2014
    Assignee: Medella Therapeutics Ltd.
    Inventors: Timothy Michael Skerry, Gareth Owain Richards
  • Antibodies against RAMP3
    Patent number: 8389237
    Abstract: The present invention provides an isolated antibody capable of binding a receptor activity modifying protein (RAMP) of CRLR receptor which antibody is of IgG, IgA or IgM isotype.
    Type: Grant
    Filed: April 23, 2008
    Date of Patent: March 5, 2013
    Assignee: Medella Therapeutics Limited
    Inventors: Timothy Michael Skerry, Gareth Owain Richards
  • THERAPEUTIC AGENT
    Publication number: 20110195076
    Abstract: The present invention relates to agents which modulate the effect of a RAMP (Receptor Activity Modifying Protein) protein on a Calcitonin Receptor Like Receptor (CRLR). Also included in the present invention are methods and uses of such agents and assays for identifying such agents. The agents of the present disclosure may be used in the treatment of, for example, cancer, obesity and other disorders.
    Type: Application
    Filed: August 3, 2010
    Publication date: August 11, 2011
    Applicant: Medella Therapeutics Ltd.
    Inventors: Timothy Michael SKERRY, Gareth Owain RICHARDS
  • ANTIBODIES AGAINST RAMP3
    Publication number: 20100111932
    Abstract: The present invention provides an isolated antibody capable of binding a receptor activity modifying protein (RAMP) of CRLR receptor which antibody is of IgG, IgA or IgM isotype.
    Type: Application
    Filed: April 23, 2008
    Publication date: May 6, 2010
    Applicant: MEDELLA THERAPEUTICS LIMITED
    Inventors: Timothy Michael Skerry, Gareth Owen Richards
  • Therapeutic Agent
    Publication number: 20080279857
    Abstract: The present invention relates to agents which modulate the effect of a RAMP (Receptor Activity Modifying Protein) protein on a Calcitonin Receptor Like Receptor (CRLR). Also included in the present invention are methods and uses of such agents and assays for identifying such agents. The agents of the present disclosure may be used in the treatment of, for example, cancer, obesity and other disorders.
    Type: Application
    Filed: October 18, 2006
    Publication date: November 13, 2008
    Applicant: THE UNIVERSITY OF SHEFFIELD
    Inventors: Timothy Michael Skerry, Gareth Owain Richards